Micro Cap
Diagnostics & Research
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Biodesix
BDSX
$205M
| $205M | $21.14 | 6.71% |
|
|
IMDX
2
Insight Molecular Diagnostics
IMDX
$156M
| $156M | $5 | 3.31% |
|
3
Exagen
XGN
$113M
| $113M | $4.86 | 3.85% |
|
|
BNR
4
Burning Rock Biotech
BNR
$106M
| $106M | $9.45 | 6.16% |
|
5
Precipio
PRPO
$41.8M
| $41.8M | $23.70 | 1.28% |
|
|
QUCY
6
Quantum Cyber N.V.
QUCY
$26.4M
| $26.4M | $1.16 | 0% |
|
7
MDxHealth
MDXH
$21.4M
| $21.4M | $0.4230 | 1.51% |
|
8
VolitionRx Ltd
VNRX
$13.6M
| $13.6M | $1.11 | 1.77% |
|
|
ADVB
9
Advanced Biomed Inc
ADVB
$11.7M
| $11.7M | $7.08 | 20.4% |
|
10
American Shared Hospital Services
AMS
$9.74M
| $9.74M | $1.45 | 1.36% |
|
11
XWELL
XWEL
$9.29M
| $9.29M | $1.07 | 2.73% |
|
|
MBAI
12
Check-Cap
MBAI
$7.34M
| $7.34M | $1.02 | 7.37% |
|
13
ENDRA Life Sciences
NDRA
$6.28M
| $6.28M | $5.36 | 8.28% |
|
14
bioAffinity Technologies
BIAF
$4.43M
| $4.43M | $0.7051 | 0.89% |
|
15
iSpecimen
ISPC
$3.25M
| $3.25M | $2.26 | 2.59% |
|
Micro Cap Diagnostics & Research Stocks at a Glance
Diagnostics and research companies run laboratory testing, imaging, and analytical services, and supply the instruments behind them. Testing volumes are recurring and largely non-discretionary, while research-tools demand follows pharma and academic R&D budgets.
There are 15 micro cap Diagnostics & Research stocks — companies in the Diagnostics & Research industry with a market cap under $250M — worth a combined $736M.
The largest by market cap are Biodesix (BDSX) at $205M, Insight Molecular Diagnostics (IMDX) at $156M and Exagen (XGN) at $113M.
Among institutional investors, Biodesix (BDSX) drew the most net new fund positions in Q1 2026: 24 funds opened new positions, taking total fund holders up 14 (54%) quarter-over-quarter.
- Combined market cap: $736M across 15 stocks.
- Micro Cap: market cap under $250M.
- Largest constituent: Biodesix (BDSX), $205M market cap.
- Most net new fund positions in Q1 2026: Biodesix (BDSX), +14 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.